These findings, unraveling cooperation between AEG-1 and MYC in generating aggressive HCC, pave the way for evaluating a combinatorial treatment strategy targeting these two proteins for HCC, which we are now actively pursuing. This evidence concerns the gene MYC and hepatocellular carcinoma.